Jason Jundt, MD
Vascular Surgery · Bend, ORNPI 1649431461
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,322 of the $15,105 with a category attached, or 68.3%. It is spread thinly across 38 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2021 at $5,200 and has fallen 69.3% since, to $1,596 in 2025.
Across 247 payments — averaging $61.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- Boston Scientific$2K
- Bard Peripheral Vascular, Inc.$1K
- Cook Medical LLC$1K
- Silk Road Medical, Inc.$1K
- Medtronic$1K
- plus $5K from 32 others
Across 18 payments — averaging $1420.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Silk Road Medical, Inc.$26K
What the payments were for
- Travel & lodging$1,55110%
- Food & beverage$10,32268%
- Education$3,23221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 1 | $3,188 |
| Boston Scientific | 68 | $2,352 |
| Bard Peripheral Vascular, Inc. | 10 | $1,144 |
| Cook Medical LLC | 20 | $1,137 |
| Silk Road Medical, Inc. | 25 | $1,122 |
| Medtronic(2 entities) | 28 | $1,083 |
| Globus Medical(2 entities) | 9 | $975 |
| Endologix LLC | 11 | $780 |
| W. L. Gore & Associates, Inc. | 7 | $694 |
| Johnson & Johnson | 18 | $526 |
| Penumbra, Inc. | 3 | $297 |
| Stryker | 3 | $249 |
| Abbott | 6 | $243 |
| Bolton Medical Inc | 2 | $230 |
| Inari Medical, Inc. | 4 | $153 |
| Siemens Medical Solutions USA, Inc. | 1 | $136 |
| Kerecis Limited | 1 | $109 |
| Philips North America LLC | 2 | $97 |
| Smith+Nephew | 3 | $79 |
| Surgenex LLC | 2 | $45 |
| Cardiva Medical, Inc. | 2 | $44 |
| Tactile Systems Technology Inc | 2 | $42 |
| Lemaitre Vascular, Inc. | 2 | $41 |
| Amgen | 2 | $37 |
| Asahi Intecc USA, Inc. | 1 | $36 |
| Convatec Inc. | 1 | $33 |
| Teleflex LLC | 2 | $29 |
| Acera Surgical, Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Shockwave Medical, Inc | 1 | $22 |
| KCI USA, Inc. | 1 | $20 |
| EKOS Corporation | 1 | $20 |
| Merit Medical Systems Inc | 1 | $20 |
| Baxter Healthcare | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Venclose Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Surmodics, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$3,188
- ALIF$864
- ENROUTE Transcarotid Neuroprotection System$574
- ENHANCE Transcarotid Peripheral Access Kit$574
- ENROUTE Transcarotid Stent System$428
- ENROUTE 0.014 Guidewire$428
- Kerecis Omega3 Marigen$328
- GENERAL VASCULAR INTERVENTION$273
- ALTO$261
- XARELTO$207
- GORE EXCLUDER AAA Endoprosthesis$175
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$174
- ARTIX MT$170
- ENDURANT IIS$167
- Indigo System$161
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$150
- ENROUTE .014 Guidewire$146
- ENROUTE Transcarotid Stent$146
- TREO ABDOMINAL STENT-GRAFT SYSTEM$145
- Cook$145
How this compares
$15,105 in reported general payments places this provider in the 80th percentile of 56 vascular surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 57 | $83,872 |
| EliquisApixaban | 67 | $79,803 |
| ClopidogrelClopidogrel Bisulfate | 218 | $3,178 |
| Cilostazol | 37 | $568 |
| Atorvastatin Calcium | 36 | $380 |
| Prednisone | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $526 | $83,87257 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 56 vascular surgery providers in Oregon.
Other vascular surgery in Bend
- Wayne NelsonBend$69K
- Paul LongBend$62K
- James BallardBend$15K
- John WiestBend$2K
- Brant UlleryWilsonville$816K
- Mark MoraschSpringfield$127K
- Cherrie AbrahamPortland$80K
- Jeffrey CrawfordCorvallis$46K
- Craig SeidmanSpringfield$20K
- John DusselWilsonville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.